<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>06931861105105</udiDi>
    <basicUdiDi>69318611ophtha0022K</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co., Ltd</manufacturerName>
    <manufacturerSrn>CN-PR-000048812</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-0.4mL</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-31T15:51:13.071Z</lastUpdated>
  </row>
  <row>
    <udiDi>06931861100254</udiDi>
    <basicUdiDi>69318611ophtha0012H</basicUdiDi>
    <tradeName>Survisc®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Shanghai Qisheng Biological Preparation Co.,Ltd</manufacturerName>
    <manufacturerSrn>CN-MF-000023601</manufacturerSrn>
    <authorisedRepresentativeName>Medical Technology Promedt Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000000085</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>15mg/mL-1.0mL</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T15:51:12.269Z</lastUpdated>
  </row>
  <row>
    <udiDi>05050474755123</udiDi>
    <basicUdiDi>5050474a000679Y</basicUdiDi>
    <tradeName>HEALON DUET PRO II</tradeName>
    <deviceName>HEALON DUET PRO II</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301016</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:40.498Z</lastUpdated>
  </row>
  <row>
    <udiDi>05050474755109</udiDi>
    <basicUdiDi>5050474a000669W</basicUdiDi>
    <tradeName>HEALON ENDOCOAT PRO</tradeName>
    <deviceName>HEALON ENDOCOAT PRO</deviceName>
    <manufacturerName>AMO Uppsala AB</manufacturerName>
    <manufacturerSrn>SE-MF-000017467</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10301012</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:58:39.706Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250906200035</udiDi>
    <basicUdiDi>425090620HA-OVDUG</basicUdiDi>
    <tradeName>VisOcu</tradeName>
    <deviceName>Opthalmic Viscosurgical Device</deviceName>
    <manufacturerName>Phibio GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000045435</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>PHI101DE-VSO</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T21:48:38.975Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001153</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName>Lubricating eye drops with 0.03% sodium hyaluronate</deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2548</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:10:39.692Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000393</udiDi>
    <basicUdiDi>4028694VISGELM7S</basicUdiDi>
    <tradeName>04028694000393</tradeName>
    <deviceName>VISMED® GEL MULTI</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000393</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:49.158Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000256</udiDi>
    <basicUdiDi>4028694VISMULTIMH</basicUdiDi>
    <tradeName>04028694000256</tradeName>
    <deviceName>VISMED® MULTI</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000256</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:48.353Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000188</udiDi>
    <basicUdiDi>4028694VISGEL2Z</basicUdiDi>
    <tradeName>04028694000188</tradeName>
    <deviceName>VISMED® GEL</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000188</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:45.431Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000133</udiDi>
    <basicUdiDi>4028694VISMED3F</basicUdiDi>
    <tradeName>04028694000133</tradeName>
    <deviceName>VISMED®</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000133</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:45.412Z</lastUpdated>
  </row>
  <row>
    <udiDi>04028694000027</udiDi>
    <basicUdiDi>4028694VISLUBE9X</basicUdiDi>
    <tradeName>04028694000027</tradeName>
    <deviceName>VISLUBE®</deviceName>
    <manufacturerName>TRB Chemedica AG</manufacturerName>
    <manufacturerSrn>DE-MF-000006919</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04028694000027</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-30T19:08:43.245Z</lastUpdated>
  </row>
  <row>
    <udiDi>04893629901379</udiDi>
    <basicUdiDi>038065GMN000009GV</basicUdiDi>
    <tradeName>ProVisc</tradeName>
    <deviceName>Provisc Ophthalmic Viscosurgical Device</deviceName>
    <manufacturerName>Alcon Laboratories, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000016248</manufacturerSrn>
    <authorisedRepresentativeName>Alcon Laboratories Belgium</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000014721</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>0005690059</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T15:30:14.676Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198926</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198926</tradeName>
    <deviceName>Sodium Hyaluronate Ophthalmic Solutions</deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>OPTIFLEX HA 10mg/ml, 1 ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T22:09:47.429Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198933</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198933</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Optiflex HA 14mg/ml, 1ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T19:59:50.104Z</lastUpdated>
  </row>
  <row>
    <udiDi>05391533198940</udiDi>
    <basicUdiDi>539153319OVDMC</basicUdiDi>
    <tradeName>05391533198940</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Biotech Europe Meditech Inc Limited</manufacturerName>
    <manufacturerSrn>IE-MF-000004695</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>Optiflex HA 24mg/ml, 1ml PFS</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-27T19:59:49.392Z</lastUpdated>
  </row>
  <row>
    <udiDi>04262479710217</udiDi>
    <basicUdiDi>426247971FTSAFE</basicUdiDi>
    <tradeName>FATS</tradeName>
    <deviceName>Sterile Viscoelastic OVD (Ophthalmic Viscosurgical Device)</deviceName>
    <manufacturerName>TBF GlobalMed. GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000042609</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>FTSA1010</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-23T19:52:11.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001368</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2493</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.859Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001795</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2643</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.391Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002150</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>56.0079</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.072Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626002280</udiDi>
    <basicUdiDi>4031626103083NM</basicUdiDi>
    <tradeName>HYLO FRESH</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.1053</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-17T15:37:02.034Z</lastUpdated>
  </row>
</eudamedExport>